Jasper therapeutics inc. jspr
WebComplete Jasper Therapeutics Inc. stock information by Barron's. View real-time JSPR stock price and news, along with industry-best analysis. Web6 apr. 2024 · Further, Jasper Therapeutics Inc. (JSPR) has a beta value of 0, and an average true range (ATR) of 0.14. Analysts have given the company’s stock an average 52-week price target of $6.21, forecast between a low of $4.00 and high of $8.00. Looking at the price targets, the low is -158.06% off current price level while to achieve the yearly ...
Jasper therapeutics inc. jspr
Did you know?
WebGet Jasper Therapeutics Inc (JSPR:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Web13 apr. 2024 · Furthermore, Jasper Therapeutics Inc. (JSPR)’s average true range (ATR) is 0.13. The company’s stock has been forecasted to trade at an average price of $6.21 over the course of the next 52 weeks, with a low of $4.00 and a high of $8.00. Based on these price targets, the low is -173.97% off current price, whereas the price has to move -447. ...
Web13 apr. 2024 · REDWOOD CITY, Calif., April 13, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on … WebJasper Therapeutics Appoints Daniel Adelman, M.D., as Acting Chief Medical Officer. REDWOOD CITY, Calif., March 23, 2024 (GLOBE NEWSWIRE) -- Jasper … REDWOOD CITY, Calif., March 09, 2024 (GLOBE NEWSWIRE) -- Jasper … The latest news and headlines from Yahoo! News. Get breaking news stories and in … Find the latest Jasper Therapeutics, Inc. (JSPR) stock discussion in Yahoo … Jasper Therapeutics, Inc. 2200 Bridge Pkwy Suite 102 Redwood City, CA 94065 … Find out all the key statistics for Jasper Therapeutics, Inc. (JSPR), including … View the basic JSPR option chain and compare options of Jasper … See Jasper Therapeutics, Inc. (JSPR) stock analyst estimates, including earnings … Find out the direct holders, institutional holders and mutual fund holders for …
Web10 apr. 2024 · Jasper Therapeutics Inc. (JSPR) full year performance was -56.12%. Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Jasper Therapeutics Inc. shares are logging -68.18% during the 52-week period from high … Web4 feb. 2024 · Individual investors among Jasper Therapeutics, Inc.'s (NASDAQ:JSPR) largest shareholders, saw gain in holdings value after stock jumped 11% last week Read full article Simply Wall St
Web23 mar. 2024 · REDWOOD CITY, Calif., March 23, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy ...
Web마감 후 결합된 회사는 Jasper Therapeutics, Inc.로 운영되며 2024년 9월 27일경에 의결권 있는 보통주와 신주인수권의 주식이 시장에서 거래를 시작할 것으로 예상됩니다. 나스닥 글로벌 셀렉트 마켓은 각각 "JSPR" 및 "JSPRW" 기호로 표시됩니다. max and tea leavesWeb17 feb. 2024 · January 30, 2024. REDWOOD CITY, Calif. , Jan. 30, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology … hermes saleWebAcum 1 zi · REDWOOD CITY, Calif., April 13, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy ... hermes samsung galaxy s5 wallet caseWebJSPR Nasdaq Stock Market • NLS real time price • CURRENCY IN USD • Pharmaceuticals. JASPER THERAPEUTICS, INC. JASPER THERAPEUTICS, INC. 1.96 ... max and the city avisWeb마감 후 결합된 회사는 Jasper Therapeutics, Inc.로 운영되며 2024년 9월 27일경에 의결권 있는 보통주와 신주인수권의 주식이 시장에서 거래를 시작할 것으로 예상됩니다. 나스닥 … max and the curse of brotherhood secretsWeb5 apr. 2024 · More Financials. Company. Jasper Therapeutics, Inc., formerly Amplitude Healthcare Acquisition Corporation, is a biotechnology company focused on hematopoietic cell transplant therapies. The Company has developed programs, such as JSP191, an anti-CD117 monoclonal antibody, which is in clinical development as a conditioning agent … max and the curse of brotherhood evil eyesWeb25 mar. 2024 · Jasper Therapeutics Inc. (JSPR) shares have gone up 113.58% during the last six months, with a year-to-date growth rate more than the industry average at 40.78% against 8.80. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 54.40% this quarter and then drop -183.30% in the quarter … hermes sandal bag charm